- Home
- KALV vs ASPN Comparison
KALV vs ASPN Comparison
Compare KALV & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- ASPN
- Stock Information
- Founded
- KALV N/A
- ASPN 2001
- Country
- KALV United States
- ASPN United States
- Employees
- KALV N/A
- ASPN N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- ASPN RETAIL: Building Materials
- Sector
- KALV Health Care
- ASPN Consumer Discretionary
- Exchange
- KALV Nasdaq
- ASPN Nasdaq
- Market Cap
- KALV 563.1M
- ASPN 570.6M
- IPO Year
- KALV N/A
- ASPN 2014
- Fundamental
- Price
- KALV $12.00
- ASPN $5.21
- Analyst Decision
- KALV Strong Buy
- ASPN Strong Buy
- Analyst Count
- KALV 8
- ASPN 11
- Target Price
- KALV $24.83
- ASPN $23.20
- AVG Volume (30 Days)
- KALV 729.1K
- ASPN 1.8M
- Earning Date
- KALV 03-12-2025
- ASPN 04-30-2025
- Dividend Yield
- KALV N/A
- ASPN N/A
- EPS Growth
- KALV N/A
- ASPN N/A
- EPS
- KALV N/A
- ASPN 0.17
- Revenue
- KALV N/A
- ASPN $452,699,000.00
- Revenue This Year
- KALV N/A
- ASPN N/A
- Revenue Next Year
- KALV N/A
- ASPN $35.45
- P/E Ratio
- KALV N/A
- ASPN $30.65
- Revenue Growth
- KALV N/A
- ASPN 89.64
- 52 Week Low
- KALV $7.30
- ASPN $4.80
- 52 Week High
- KALV $15.50
- ASPN $33.15
- Technical
- Relative Strength Index (RSI)
- KALV 55.34
- ASPN 31.18
- Support Level
- KALV $11.42
- ASPN $4.91
- Resistance Level
- KALV $12.35
- ASPN $5.47
- Average True Range (ATR)
- KALV 0.96
- ASPN 0.42
- MACD
- KALV 0.04
- ASPN 0.03
- Stochastic Oscillator
- KALV 88.74
- ASPN 23.98
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.